Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

4results about How to "Clear design ideas" patented technology

Traditional Chinese medicine composition for dispelling effects of alcohol as well as preparation method, application and product of traditional Chinese medicine composition

The invention belongs to the field of traditional Chinese medicine compositions, and particularly relates to a sobering and hangover alleviating traditional Chinese medicine composition which comprises a component A and a component B, wherein the component A comprises a component a, a component b, a component c and a component d; the component B comprises a component e, a component f, a component g and a component h; in the component A, the component a is radix puerariae and an extract thereof; the component b is rhizoma polygonati and an extract thereof; the component c is poria cocos and an extract thereof; the component d is lily and an extract thereof; in the component B, the component e is radix ophiopogonis and an extract thereof; the component f is fructus lycii and an extract thereof; the component g is konjak and an extract thereof; the component h is orange peel and an extract thereof. The eight medicines are combined and can realize synergism, and excellent sobering and hangover alleviating effects can be obtained. The traditional Chinese medicine composition disclosed by the invention can have better sobering and hangover alleviating functions on the basis of the combined action of multiple mechanisms of metabolism acceleration, organ protection and system conditioning, and the components in the traditional Chinese medicine composition all belong to safe raw materials with homology of medicine and food.
Owner:MEDONCARE PHARMA CO LTD

Six-phase reactor for energy storage converter

This invention discloses a six-phase reactor for an energy storage converter, belonging to the field of reactor technology. It includes a first reactor assembly and a second reactor assembly. The first reactor assembly includes a first base, which is composed of a U-shaped support plate and an L-shaped support plate, allowing for independent and stable placement. The second reactor assembly includes a second base, mainly composed of an L-shaped support plate, which is temporarily stabilized during manufacturing using a detachable support fixture. After each reactor assembly independently completes overall impregnation and drying, the support fixture is removed. Then, the surfaces of the terminals and connectors to be connected in parallel are polished and the paint is removed. The two bases are then fixed using base connectors, and the corresponding phase terminals are electrically connected in parallel using a phase-parallel connector to form a six-phase output. This invention, through differentiated base design and fixture assistance, allows the two reactors to be impregnated separately before being connected in parallel, balancing impregnation process quality and electrical connection reliability, and also helps to reduce the overall size of the unit.
Owner:HEFEI ECRIEE TAMURA ELECTRIC

A skew grid tube structure non-coplanar x-shaped conversion node and a design method thereof

ActiveCN121251018BImprove versatilityReasonable and clear structure
The application provides a skew grid cylinder structure non-coplanar X type conversion node and a design method thereof, and solves problems of complex node manufacturing process, low construction efficiency, difficult connection, poor stress, difficult manufacturing and the like. The upper and lower ends of the center circular tube are fixed with cover plates, two inclined columns at the upper part of the X type conversion node are fixed on the cover plate at the upper end of the center circular tube, and two inclined columns at the lower part are fixed on the cover plate at the lower end of the center circular tube; the middle part of the vertical through type connecting plate vertically penetrates the center circular tube; the upper part and the lower part of the vertical through type connecting plate vertically penetrate the cover plates at the upper and lower ends respectively and are located between the two inclined columns of the X type conversion node; the inclined columns at the upper and lower parts are respectively inserted and fixed with inclined column inner insertion plates, and the inclined column inner insertion plates are respectively fixed with the cover plates and the vertical through type connecting plate; the inner stiffening plates are respectively fixed with the center circular tube, the cover plates at the upper and lower ends and the vertical through type connecting plate; and the outer stiffening plates are respectively fixed with the cover plates at the upper and lower ends and the center circular tube.
Owner:CHINA UNITED ENG

An adaptive drug delivery system for ischemic stroke, its preparation method and application

ActiveCN115887688BSolve the problem of medication discrepanciesAchieving Adaptive TherapyAntipyreticTetracycline active ingredientsChemical reactionInjury brain
This invention discloses an adaptive drug delivery system for ischemic stroke, its preparation method, and its application. MMP-2 responsive peptide-drug dimers are loaded onto the surface of mesoporous polydopamine for intervention or treatment of cerebral ischemia-reperfusion injury. The system allows for targeted drug delivery based on individual differences in disease progression among patients, precisely promoting brain injury repair. This invention applies MMP-2 responsive peptides to the treatment of ischemic stroke, using mesoporous polydopamine as a drug carrier, providing reactive sites and loading space for efficient drug loading. The chemical reaction between catechol on the polydopamine surface and the thiol groups on the MMP-2 responsive peptides loads the peptide-drug dimers, thereby achieving responsive drug release on the carrier surface. Simultaneously, this invention utilizes the ability of polydopamine to scavenge reactive oxygen species (ROS), rapidly clearing local ROS and reducing acute damage caused by ischemic stroke.
Owner:ZHEJIANG CHINESE MEDICAL UNIVERSITY